By Dr Deepu
Healio (8/28) reports that the National Institutes of Health “has announced plans for its National Institute of Allergy and Infectious Diseases to conduct a pilot study to evaluate how respiratory syncytial virus infection develops in adults, and how it affects immune system responses, according to a press release.” NIAID Director Dr. Anthony Fauci said the study will enable “scientists to monitor, in a controlled setting, the natural history of a disease in exquisite detail.” He added, “By studying [respiratory syncytial virus] infection in healthy adults, we hope to improve understanding of how this infection develops and determine the suitability of this particular strain of the virus for use in future [respiratory syncytial virus] vaccine and treatment trials.”
Healio (8/28) reports that the National Institutes of Health “has announced plans for its National Institute of Allergy and Infectious Diseases to conduct a pilot study to evaluate how respiratory syncytial virus infection develops in adults, and how it affects immune system responses, according to a press release.” NIAID Director Dr. Anthony Fauci said the study will enable “scientists to monitor, in a controlled setting, the natural history of a disease in exquisite detail.” He added, “By studying [respiratory syncytial virus] infection in healthy adults, we hope to improve understanding of how this infection develops and determine the suitability of this particular strain of the virus for use in future [respiratory syncytial virus] vaccine and treatment trials.”
No comments:
Post a Comment
Please leave your comments